Ireland
--:--IST
Latest
Clinical Trials in Singapore / NCT05709327
Active, not recruiting Not applicable

Integrating Smart Ring Wearable Technology in Pregnancy Health Monitoring (I-SMART)

NCT05709327 · tracked via the Priya Life Science Singapore tracker
Phase
Not applicable
Started
2023-09-03
Last updated
2026-08-10

Condition(s) studied

Pregnancy

Investigational drug(s) / intervention(s)

Integrating Smart Ring Wearable Technology in Pregnancy Health Monitoring (I-SMART)

Integrating Smart Ring Wearable Technology in Pregnancy Health Monitoring (I-SMART): Single-arm observational study where all participants in the study will be given a smart ring (Oura Ring) to wear throughout the duration of the study.

Study summary

This study aims to test the following hypotheses in a single-arm observational study in 70-100 healthy pregnant multi-ethnic women who will be followed-up from the first trimester of pregnancy to the third trimester of pregnancy.

Aim 1: To assess the applicability, acceptability and compliance with the use of a wearable smart ring together with smart digital devices (e.g., smart phone) during pregnancy.

Hypothesis 1: The investigators hypothesize that participants will respond favorably to the use of the smart ring to monitor their physical activity and sleep during pregnancy.

Aim 2: To assess the association between maternal characteristics (age, pre-pregnancy BMI, pregnancy weight gain, stress, anxiety and depression symptoms) with physical activity markers (energy expenditure, and step count) and sleep markers (duration, quality, sleep onset latency, wake after sleep onset, time in bed and heart rate variability) collected from the smart ring in the second trimester of pregnancy.

Hypothesis 2: The investigators hypothesize that specific maternal characteristics will be associated with physical activity markers (energy expenditure, and step count), as well as sleep markers (duration, quality, sleep onset latency, wake after sleep onset, time in bed and heart rate variability).

Eligibility

Sex
FEMALE
Min age
21 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion criteria: 1. From the first to third trimester of pregnancy (4-39 weeks of gestational age) 2. Mobile phone's operating system supported by the smart ring application. 3. Aged 21 and above Exclusion criteria: 1. Can't read or speak English 2. Below 21 years of age 3. Below or above gestational age limit 4. Limited mobility 5. Diagnosed with severe unstable mental conditions 6. Diagnosed with severe chronic disorders 7. Mobile device not compatible with smart ring

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
KK Women's and Children's Hospital Singapore Singapore

More KK Women's and Children's Hospital trials in Singapore

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05709327 on ClinicalTrials.gov ↗ ← All trials in Singapore